Aveo pharmaceuticals, inc. – product pipeline review – 2012
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
AVEO Pharmaceuticals, Inc. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “AVEO Pharmaceuticals, Inc. -
Product Pipeline Review - 2012” provides data on the AVEO Pharmaceuticals, Inc.’s
research and development focus. The report includes information on current
developmental pipeline, complete with latest updates, and features on discontinued
and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, AVEO Pharmaceuticals, Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from AVEO
Pharmaceuticals, Inc. and industry-specific third party sources, put together by
Global Markets Direct’s team.
Scope
- AVEO Pharmaceuticals, Inc. - Brief AVEO Pharmaceuticals, Inc. overview including
business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AVEO Pharmaceuticals, Inc. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
2. List of Tables 6
List of Figures 7
AVEO Pharmaceuticals, Inc. Snapshot 8
AVEO Pharmaceuticals, Inc. Overview 8
Key Information 8
Key Facts 8
AVEO Pharmaceuticals, Inc. – Research and Development Overview 9
Key Therapeutic Areas 9
AVEO Pharmaceuticals, Inc. – Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products – Monotherapy 13
Pipeline Products – Combination Treatment Modalities 14
AVEO Pharmaceuticals, Inc. – Pipeline Products Glance 15
AVEO Pharmaceuticals, Inc. – Late Stage Pipeline 15
Phase III Products/Combination Treatment Modalities 15
AVEO Pharmaceuticals, Inc. Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Phase I Products/Combination Treatment Modalities 17
AVEO Pharmaceuticals, Inc. – Early Stage Pipeline Products 18
Pre-Clinical Products/Combination Treatment Modalities 18
Discovery Products/Combination Treatment Modalities 19
AVEO Pharmaceuticals, Inc. – Drug Profiles 20
AV-203 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AV-232 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AV-299 + Gefitinib 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AV-299 + Tarceva 24
3. Product Description 24
Mechanism of Action 24
R&D Progress 24
FGFR1 Inhibitory Monoclonal Antibody 25
Product Description 25
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Adamis Pharmaceuticals Corporation – Product Pipeline Review – 2012
7TM Pharma A/S – Product Pipeline Review – 2012
AVEO Pharmaceuticals, Inc. – Product Pipeline Review – 2012
BioSante Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Biotie Therapies Corp. – Product Pipeline Review – 2012
Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012
Celtic Biotech, Ltd. – Product Pipeline Review – 2012
4. Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012
Endocyte, Inc. – Product Pipeline Review – 2012
Flamel Technologies S.A. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com